Soligenix, Inc. (SNGX)
Develops medicines for rare diseases and vaccines for infectious disease threats.
$0.36-0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-86.8%
The outlook
SNGX is trading near its 52-week lows, well below both its 50- and 200-day moving averages. Analyst coverage shows an average price target roughly 4× the current price, though overall sentiment leans bearish. The stock sits at the extreme bottom of its yearly range.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +384% vs current price
Analyst price target
~12-month · 2 analysts$1.75average target+384.0% vs now
Now $0.36
Low $1.50High $2.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$5.4M
52-wk high
$6.23
52-wk low
$0.28
50-day avg
$0.44
200-day avg
$1.06
Trailing P/E
—